EDITORIAL
Published on 25 Jan 2023
Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
doi 10.3389/fnins.2023.1034158
- 1,506 views
- 1 citation
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Beta-Amyloid Oligomer Specific Treatments for Alzheimer’s Disease
Beta-Amyloid Oligomer Specific Treatments for Alzheimer’s Disease
10k
Total Downloads
48k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 23 Aug 2022
Oligomeropathies, inflammation and prion protein binding
doi 10.3389/fnins.2022.822420
- 2,231 views
- 4 citations
REVIEW
Published on 26 Apr 2022
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
doi 10.3389/fnins.2022.848215
- 9,304 views
- 24 citations
ORIGINAL RESEARCH
Published on 18 Jan 2022
TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline
doi 10.3389/fphar.2021.763866
- 7,318 views
- 36 citations
ORIGINAL RESEARCH
Published on 03 Jan 2022
The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
doi 10.3389/fnins.2021.768646
- 4,581 views
- 19 citations
ORIGINAL RESEARCH
Published on 13 Dec 2021
Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice
doi 10.3389/fnins.2021.763476
- 18,395 views
- 20 citations
Published in
Frontiers in Neuroscience
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 48kTopic views
- 37kArticle views
- 10kArticle downloads